|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/48 | (2006.01) |
| C12N 9/64 | (2006.01) | ||
| A61P 7/04 | (2006.01) |
| (11) | Number of the document | 2193196 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08834136.7 |
| Date of filing the European patent application | 2008-09-26 | |
| (97) | Date of publication of the European application | 2010-06-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-13 |
| (46) | Date of publication of the claims translation | 2016-12-12 |
| (86) | Number | PCT/US2008/078014 |
| Date | 2008-09-26 |
| (87) | Number | WO 2009/042962 |
| Date | 2009-04-02 |
| (30) | Number | Date | Country code |
| 976343 P | 2007-09-28 | US | |
| 90574 P | 2008-08-20 | US |
| (72) |
LU, Genmin, US
PHILLIPS, David R., US
ANDRE, Patrick, US
SINHA, Uma, US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Faktoriaus Xa inhibitorių antidotai ir jų panaudojimo būdai |
| ANTIDOTES FOR FACTOR Xa INHIBITORS AND METHODS OF USING THE SAME |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 18 | 347.00 EUR |
| 2026-09-26 |